Skip to Main Content

Sawai Launches Tadalafil Tablets

Osaka, Japan – March 6, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) announced the launch dates with the below-mentioned schedule for Tadalafil tablets (the branded product: Cialis®).

Tadalafil tablets are prescribed for the treatment of erectile dysfunction.

Product Name     Launch Date
TADALAFIL Tablets 10 mg CI [SAWAI]    March 26, 2020
TADALAFIL Tablets 20 mg CI [SAWAI]    March 19, 2020

The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.

Contact Information

PR / IR Group, Corporate Strategy Department, Sawai Pharmaceutical Co., Ltd.
E-mail: koho@sawai.co.jp